Ireland
--:--IST
Latest
Active, not recruiting Observational

Accuracy Comparison: Optoelectronic Motion Capture and Markerless System

NCT06544824 · tracked via the Priya Life Science Italy tracker
Phase
Observational
Started
2024-05-15
Last updated
2026-02-27

Condition(s) studied

Children, AdultMotor Disorders

Investigational drug(s) / intervention(s)

Measure gait spatiotemporal parameters and kinematics from optoelectronic systemMeasure gait spatiotemporal parameters and kinematics from markerless systemQuantify tip toe step during gait from kinematic

Measure gait spatiotemporal parameters and kinematics from optoelectronic system: The raw data acquired from motion capture system were processed with Smart Analyzer software (BTS Bioengineering, Milano, Italy). First, the 3D data were filtered and interpolated in case of missing data for short time. Then spatial-temporal parameters (cycle duration, cadence, gait speed, stance phase, swing phase, double-support phase, stride length and step width) and conventional kinematic parameters of traditional Davis marker-set protocols were computed.

Measure gait spatiotemporal parameters and kinematics from markerless system: The two videos were elaborated using OpenPose that returns a set of 25 2D keypoints coordinates for body pose estimation for each video. Key-points were located in relevant body landmarks and it were used to determine the 2D Cartesian coordinates on the sagittal plane and on the frontal plane. The data calculated with routines were filtered and interpolated in case of missing data. With respect to kinematic parameters, the segment and joint angles were measured from the estimated feature points of each joint. Spatiotemporal gait parameters were calculated using successive heel strike and toe-off events.

Quantify tip toe step during gait from kinematic: The kinematic features calculated are used to identify and count the number of tip toe steps during gait or standing

Study summary

The purpose of this study was to assess the Openpose reliability to measure kinematics and spatiotemporal gait parameters and to evaluate the minimum technical requirements. This analysis used video and optoelectronic motion capture simultaneously recorded. We assessed more of 20 subject with different motor gait impairments

Eligibility

Sex
ALL
Min age
4 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Age over 4 years; * Ability to walk independently without walking aids and/or orthoses. Exclusion Criteria: * Inability to walk independently and safely for short distances without walking aids and/or orthoses.

Primary outcome measure(s)

  • Absolute Error — Through study completion, an average of 1 year
    Absolute errors were calculated for the kinematics parameters and for each spatiotemporal variable by taking the absolute value after subtracting the values obtained using pose estimation methods from the value measured using markerbased motion capture
  • intraclass correlation coefficients — Through study completion, an average of 1 year
    To confirm whether the data obtained by OpenPose agreed with the data from the optoelectronic system, investigators calculated the ICCs (two-way mixed effects model, absolute agreement, average measurements) between the spatiotemporal and kinematic data from both systems. The ICC values were interpreted as follows: poor agreement for ICC \< 0.5, moderate agreement for values between 0.5 and 0.75, good agreement for values between 0.75 and 0.9, and excellent agreement for values greater than 0.90.
  • cross-correlation coefficients — Through study completion, an average of 1 year
    The cross-correlation coefficients (CCC) between both systems were used to evaluate the similarity of angles during the gait cycle. The CCC values were interpreted as follows: weak or no coupling for values between -0.3 and 0.3, moderate coupling for values between 0.3 and 0.7 or -0.7 and -0.3, and strong coupling for values greater than 0.7 or less than -0.7.

Trial sites (1)

FacilityCityRegionStatus
IRCCS E. Medea Bosisio Parini Italy
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06544824 on ClinicalTrials.gov ↗ ← All trials in Italy